Real-World Use of BTK Inhibitors in Chronic Lymphocytic Leukemia - Episode 3
Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss findings from the SEQUOIA trial of zanubrutinib in treatment-naive chronic lymphocytic leukemia.
Related Content: